Metallothionein-1 messenger RNA transcription in steroid-secreting cells of the rat ovary during the periovulatory period

Biology of Reproduction

Volumn 68, Issue 5, 2003, Pages 1895-1902

  Espey, L L ^a   Ujioka, T ^a   Okamura, H ^b   Richards, J S ^c  

^a TRINITY UNIVERSITY   (United States)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Corpus luteum; Follicle; Ovary; Ovulation; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN DERIVATIVE; DISINTEGRIN; MESSENGER RNA; METALLOPROTEINASE; METALLOTHIONEIN; METALLOTHIONEIN I; STEROID; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; IN SITU HYBRIDIZATION; INFLAMMATION; LUTEINIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY; OVARY FOLLICLE; OVULATION; OVULATION INDUCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSCRIPTION; STEROID RELEASE; THECA CELL;

ABORTIFACIENT AGENTS; ADAM PROTEINS; ANDROSTENOLS; ANIMALS; BLOTTING, NORTHERN; CORPUS LUTEUM; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISINTEGRINS; DNA, COMPLEMENTARY; FEMALE; IN SITU HYBRIDIZATION; INDOMETHACIN; METALLOENDOPEPTIDASES; METALLOTHIONEIN; OVARIAN FOLLICLE; OVARY; OVULATION; PROGESTERONE; RATS; RATS, WISTAR; RNA, MESSENGER; STEROIDS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION, GENETIC;

ANIMALIA; EUKARYOTA; FALLOPIA; RATTUS NORVEGICUS;

EID: 0037408209     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.013557     Document Type: Article

References (40)

1. Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000; 35:35-70.
2. Kang YJ. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 1999; 222:263-273.
3. Maret W. The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 2000; 130(suppl 5S): 1455S-1458S.
4. Samson SL, Gedamu L. Molecular analyses of metallothionein gene regulation. Prog Nucleic Acid Res Mol Biol 1998; 59:257-288.
5. Klaassen CD, Liu J, Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 1999; 39:267-294.
6. Davis SR, Cousins RJ. Metallothionein expression in animals: a physiological perspective on function. J Nutr 2000; 130:1085-1088.
7. Simpkins CO. Metallothionein in human disease. Cell Mol Biol 2000; 46:465-488,
8. Espey LL, Yoshioka S, Russell DL, Robker RL, Fujii S, Richards JS. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat. Biol Reprod 2000; 62:1090-1095.
9. Chun SY, Popliker M, Reich R, Tsafriri A. Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary. Biol Reprod 1992; 47:245-253.
10. Mann JS, Kindy MS, Hyde JF, Clark MR, Curry TE Jr. Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor reduction. Biol Reprod 1993; 48:1006-1013.
11. Espey LL. Ovulation as an inflammatory reaction: a hypothesis. Biol Reprod 1980; 22:73-106.
12. Espey LL, Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994; 50: 233-238.
13. Penkowa M, Hidalgo J. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment. Exp Neurol 2000; 163:72-84.
14. Bruwer M, Schmid KW, Metz KA, Krieglstein CF, Senninger N, Schurmann G. Increased expression of metallothionein in inflammatory bowel disease. Inflamm Res 2001; 50:289-293.
15. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J. Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol 2002; 173:114-128.
16. Youn J, Hwang SH, Ryoo ZY, Lynes MA, Paik DJ, Chung HS, Kim HY. Metallothionein suppresses collagen-induced arthritis via induction of TGF-β and down-regulation of proinflammatory mediators. Clin Exp Immunol 2002; 129:232-239.
17. Espey LL, Yoshioka S, Russell D, Ujioka T, Vladu B, Skelsey M, Fujii S, Okamura H, Richards JS. Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropinprimed immature rat. Biol Reprod 2000; 62:390-397.
18. Espey LL, Miller DH, Margolius HS. Ovarian increase in kinin-generating capacity in PMSG/hCG-primed immature rat. Am J Physiol 1986; 251:E362-E365.
19. Espey LL, Tanaka N, Okamura H. Increase in ovarian leukotrienes during hormonally induced ovulation in the rat. Am J Physiol 1989; 256:E753-E759.
20. Palmiter RD. The elusive function of metallothioneins. Proc Natl Acad Sci U S A 1998; 95:8428-8430.
21. Hidalgo J, Carrasco J. Regulation of the synthesis of brain metallothioneins. Neurotoxicology 1998; 19:661-666.
22. Vasak M, Kagi JHR. Metallothioneins. In: King RB (ed.), Encyclopedia of Inorganic Chemistry, vol. 4. New York: Wiley; 1994: 2229-2241.
23. Slater EP, Cato AC, Karin M, Baxter JD, Beato M. Progesterone induction of metallothionein-IIA gene expression. Mol Endocrinol 1988; 2:485-491.
24. Beato M, Chalepakis G, Schauer M, Slater EP. DNA regulatory elements for steroid hormones. J Steroid Biochem 1989; 32:737-747.
25. Viarengo A, Burlando B, Ceratto N, Panfoli I. Antioxidant role of metallothioneins: a comparative overview. Cell Mol Biol 2000; 46: 407-417.
26. Moffatt P, Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab Rev 1997; 29:261-307.
27. Nishimura N, Nishimura H, Tohyama C. Localization of metallothionein in female reproductive organs of rat and guinea pig. J Histochem Cytochem 1989; 37:1601-1607.
28. Espey LL, Ujioka T, Russell DL, Skelsey M, Vladu B, Robker RL, Okamura H, Richards JS. Induction of early growth response protein-1 gene expression in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Endocrinology 2000; 141:2385-2391.
29. Hedin L, Rodgers RJ, Simpson ER, Richards JS. Changes in content of cytochrome P450 17α, cytochrome P450s6c and 3-hydroxy-3-methyl CoA reductase in developing rat ovarian follicles and corpora lutea: correlation with theca cell steroidogenesis. Biol Reprod 1987; 37:211-223.
30. Hickey GJ, Chen S, Besman MJ, Shively JE, Hall PF, Gaddy-Kurten D, Richards JS. Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea; relationship to estradiol biosynthesis. Endocrinology 1988; 122:1426-1436.
31. Fitzpatrick SL, Carlone DL, Robker RL, Richards JS. Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge. Steroids 1997; 62:197-206.
32. Ronen-Fuhrmann T, Timberg R, King SR, Hales KH, Hales DB, Stocco DM, Orly J. Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 1998; 139:303-315,
33. Espey LL. Ovulation. In: Knobil E, Neill JD (eds.), Encyclopedia of Reproduction, vol. 3, San Diego: Academic Press; 1994: 605-614.
34. Adashi EY. The potential role of interleukin-1 in the ovulatory process: an evolving hypothesis. Mol Cell Endocrinol 1998; 140:77-81.
35. Terranova PF, Rice VM. Review: cytokine involvement in ovarian processes. Am J Reprod Immunol 1997; 37:50-63.
36. Sobocinski PZ, Canterbury WJ Jr. Hepatic metallothionein induction in inflammation. Ann N Y Acad Sci 1982; 389:354-367.
37. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002; 59:627-647.
38. Penkowa M, Carrasco J, Giralt M, Molinero A, Hernandez J, Campbell IL, Hidalgo J. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice. J Cereb Blood Flow Metab 2000; 20:1174-1189.
39. Penkowa M, Hidalgo J. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-α and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE). Exp Neurol 2001; 170:1-14.
40. Penkowa M, Poulsen C, Carrasco J, Hidalgo J. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment, Exp Neurol 2002; 176:308-321.